Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study.
Titanium dioxide nanoparticles (nanoTiO(2) ) are used in various applications including in paints. NanoTiO(2) inhalation may induce pulmonary toxicity and systemic effects. However, the underlying molecular mechanisms are poorly understood. In this study, the effects of inhaled surface-coated nanoTiO(2) on pulmonary global messenger RNA (mRNA) and microRNA (miRNA) expression in mouse were characterized to provide insight into the molecular response. Female C57BL/6BomTac mice were exposed for 1 hr daily to 42.4 ± 2.9 (SEM) mg surface-coated nanoTiO(2) /m(3) for 11 consecutive days by inhalation and were sacrificed 5 days following the last exposure. Physicochemical properties of the particles were determined. Pulmonary response to nanoTiO(2) was characterized using DNA microarrays and pathway-specific PCR arrays and related to data on pulmonary inflammation from bronchial lavages. NanoTiO(2) exposure resulted in increased levels of mRNA for acute phase markers serum amyloid A-1 (Saa1) and serum amyloid A-3 (Saa3), several C-X-C and C-C motif chemokines, and cytokine tumor necrosis factor genes. Protein analysis of Saa1 and 3 showed selective upregulation of Saa3 in lung tissues. Sixteen miRNAs were induced by more than 1.2-fold (adjusted P-value < 0.05) following exposure. Real time polymerase chain reaction confirmed the upregulation of miR-1, miR-449a and revealed dramatic induction of miR-135b (60-fold). Thus, inhalation of surface-coated nanoTiO(2) results in changes in the expression of genes associated with acute phase, inflammation and immune response 5 days post exposure with concomitant changes in several miRNAs. The role of these miRNAs in pulmonary response to inhaled particles is unknown and warrants further research.
Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada. sabina.halappanavar@hc-sc.gc.ca
Sabina
S
Halappanavar
Petra
P
Jackson
Andrew
A
Williams
Keld A
KA
Jensen
Karin S
KS
Hougaard
Ulla
U
Vogel
Carole L
CL
Yauk
Håkan
H
Wallin
D000818:Animals; D018925:Chemokines / Q000378:metabolism; D005260:Female; D008168:Lung / Q000187:drug effects* / Q000378:metabolism*; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D000685:Serum Amyloid A Protein / Q000235:genetics / Q000378:metabolism; D014025:Titanium / Q000009:adverse effects*; D043922:Toxicogenetics / Q000379:methods*
D018925:Chemokines; D035683:MicroRNAs; C489995:Saa2 protein, mouse; C076498:Saa3 protein, mouse; D000685:Serum Amyloid A Protein; C009495:titanium dioxide; D014025:Titanium
Occup Environ Med. 2004 May;61(5):442-7
15090666
Part Fibre Toxicol. 2009 Apr 20;6:12
19374780
Part Fibre Toxicol. 2008 Mar 11;5:3
18331653
J Cell Physiol. 2009 Jan;218(1):22-5
18767038
Cell Cycle. 2008 Oct;7(20):3143-8
18843198
Eur Respir J. 2006 Aug;28(2):275-85
16641123
Nat Cell Biol. 2009 Mar;11(3):228-34
19255566
Oncogene. 2009 Apr 9;28(14):1714-24
19252524
Toxicol Sci. 2004 Feb;77(2):347-57
14600271
Toxicol Sci. 2008 Jun;103(2):228-40
18281715
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8961-5
11470909
Toxicol Appl Pharmacol. 2003 Jun 1;189(2):84-95
12781626
Clin Genet. 2008 Oct;74(4):307-15
18713257
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13790-5
11707567
Nucleic Acids Res. 2002 May 1;30(9):e36
11972351
Biochem Biophys Res Commun. 1988 Nov 30;157(1):271-7
2461709
Inhal Toxicol. 2007;19 Suppl 1:205-12
17886069
Toxicol Appl Pharmacol. 1997 Jul;145(1):10-22
9221819
Nat Rev Mol Cell Biol. 2009 Feb;10(2):126-39
19165215
Part Fibre Toxicol. 2005 Oct 06;2:8
16209704
Toxicology. 2010 Sep 10;275(1-3):65-71
20540983
J Occup Environ Med. 2006 Dec;48(12):1308-13
17159646
Toxicol Sci. 2006 May;91(1):227-36
16495353
BMC Bioinformatics. 2010 Jan 28;11:60
20109181
Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14895-900
15469929
Nat Protoc. 2009;4(1):44-57
19131956
Proc Natl Acad Sci U S A. 1981 Aug;78(8):4718-22
6946420
Part Fibre Toxicol. 2010 Jun 14;7:16
20546558
J Biol Chem. 1986 Jun 25;261(18):8453-61
2424896
Toxicol Lett. 2009 May 8;186(3):152-9
19114093
Cell Cycle. 2007 Sep 1;6(17):2127-32
17786041
Genet Res. 2007 Dec;89(5-6):509-14
18976541
J Immunol. 2005 Jul 1;175(1):376-84
15972671
Toxicol Lett. 2010 Oct 5;198(2):100-5
20599482
BMC Cancer. 2009 Nov 18;9:401
19922656
Environ Health Perspect. 2002 Aug;110(8):797-800
12153761
Am J Respir Cell Mol Biol. 2004 Dec;31(6):595-600
15284076
Methods Mol Biol. 2010;597:227-41
20013237
Toxicol Sci. 2010 Feb;113(2):422-33
19875681
Lung. 1999;177(1):9-19
9835630
Environ Health Perspect. 2009 Nov;117(11):1745-51
20049127
FASEB J. 2006 Nov;20(13):2393-5
17023518
J Immunol. 1995 Jan 15;154(2):825-31
7814886
Part Fibre Toxicol. 2006 Aug 14;3:11
16907977
Biostatistics. 2005 Jan;6(1):59-75
15618528
Toxicol Sci. 2002 Nov;70(1):86-97
12388838
Am J Respir Cell Mol Biol. 1993 Mar;8(3):311-8
8383510
J Immunol. 2009 Apr 15;182(8):4994-5002
19342679
Gene. 2008 Dec 15;426(1-2):57-64
18805469
J Am Acad Dermatol. 2008 Nov;59(5):725-37; quiz 738-40
19119093
Part Fibre Toxicol. 2009 Jan 12;6:2
19138394
J Exp Med. 1986 Dec 1;164(6):2006-17
3783088
Toxicol Appl Pharmacol. 1985 Jun 30;79(2):179-92
4002222
J Toxicol Environ Health A. 2008;71(13-14):976-80
18569605
Am J Respir Cell Mol Biol. 2011 Feb;44(2):185-96
20378750
Cell. 2007 Jun 29;129(7):1401-14
17604727
Mutat Res. 2007 Apr 2;628(2):99-106
17223607
Biochem J. 1998 Sep 15;334 ( Pt 3):489-503
9729453
J Transl Med. 2008 Jul 22;6:39
18647411
Circ J. 2009 Aug;73(8):1492-7
19521018
J Appl Toxicol. 2009 May;29(4):330-7
19156710
Environ Health Perspect. 2005 Jul;113(7):823-39
16002369
Cell. 2000 Jan 7;100(1):57-70
10647931
Annu Rev Med. 2009;60:167-79
19630570
Toxicology. 2009 Jun 16;260(1-3):37-46
19464567
J Toxicol Environ Health A. 2002 Oct 25;65(20):1531-43
12396867
Toxicology. 2008 Apr 3;246(1):34-9
18289762
Curr Opin Pharmacol. 2009 Aug;9(4):514-20
19525145
Am J Respir Cell Mol Biol. 2005 Mar;32(3):169-76
15713815
Am J Respir Cell Mol Biol. 2004 Dec;31(6):601-10
15374838
Nat Rev Genet. 2009 Oct;10(10):704-14
19763153
J Immunol. 2008 May 1;180(9):6262-9
18424749
Nature. 2004 Dec 16;432(7019):917-21
15531878
Toxicol Sci. 2005 Dec;88(2):514-24
16177240
Inhal Toxicol. 2000 Dec;12(12):1113-26
11114784
Am J Respir Cell Mol Biol. 2005 Jun;32(6):531-9
15778492
Biol Rev Camb Philos Soc. 2009 Feb;84(1):55-71
19046400
Inhal Toxicol. 2009 Feb;21(2):102-18
18800274
Environ Health Perspect. 2004 Mar;112(3):339-45
14998750
Am J Respir Crit Care Med. 2006 Feb 15;173(4):432-41
16293802
Inhal Toxicol. 2004 Jun;16(6-7):437-45
15204759
Bioinformatics. 2003 Jan 22;19(2):185-93
12538238
Toxicol Sci. 2006 Jul;92(1):174-85
16613837
Nat Cell Biol. 2008 Nov;10(11):1349-55
18820689
Inhal Toxicol. 2000 Dec;12(12):1089-111
11114783
Regul Toxicol Pharmacol. 1995 Feb;21(1):123-35
7784625
Vet Pathol. 1997 Nov;34(6):592-7
9396140
Int J Biochem Cell Biol. 2009 Jan;41(1):87-95
18834952
Biometrics. 2003 Dec;59(4):822-8
14969460
Clin Exp Allergy. 2006 Nov;36(11):1469-79
17083358